22 September 2019
: Case report
A Rare Coexistence of Medullary Thyroid Cancer with Graves Disease: A Case Report and Systematic Review of the Literature
Rare disease
Konstantinos Sapalidis1AE, Anastasios Papanastasiou1EF*, Nikolaos Michalopoulos1B, Stylianos Mantalovas1B, Dimitrios Giannakidis1ABCDEFG, Georgios D. Koimtzis1FG, Maria Florou1F, Christos Poulios2B, Niki Mantha2B, Isaak I. Kesisoglou1AEDOI: 10.12659/AJCR.917642
Am J Case Rep 2019; 20:1398-1401
Abstract
BACKGROUND: Graves disease is occasionally associated with thyroid cancer. The most common histological type of thyroid cancer in patients with Graves disease is papillary followed by follicular. Medullary thyroid cancer and Graves disease have been reported simultaneously only in a few cases in the literature.
CASE REPORT: A case of coexistence of Graves disease and medullary thyroid cancer is described in this report. The patient was diagnosed with Graves disease 8 years ago. Although he had an initial successful treatment with carbimazole, in the last 2 years no steady euthyroid function was achieved. Total thyroidectomy was considered as the optimal treatment. An incidental medullary microcarcinoma with maximum diameter 0.5 cm was identified by pathology report.
CONCLUSIONS: Medullary thyroid cancer has been reported in patients with Graves disease in 15 cases, including the current case. Medullary thyroid cancer is aggressive, and a delayed diagnosis would be harmful. Hence, patients with Graves disease should be evaluated regularly by a thyroid specialist.
Keywords: Carcinoma, Medullary, Graves Disease, Thyroidectomy, Carcinoma, Neuroendocrine, Incidental Findings
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946215
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946869
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Most Viewed Current Articles
21 Jun 2024 : Case report
94,176
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,416
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,562
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,092
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030